Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct;86(1):1-14.
doi: 10.1007/s12020-024-03855-8. Epub 2024 May 10.

The efficiency of stem cell differentiation into functional beta cells for treating insulin-requiring diabetes: Recent advances and current challenges

Yunfei Luo  1 , Peng Yu  1 , Jianping Liu  2
Affiliations
Review

The efficiency of stem cell differentiation into functional beta cells for treating insulin-requiring diabetes: Recent advances and current challenges

Yunfei Luo et al. Endocrine. 2024 Oct.

Abstract

In recent years, the potential of stem cells (SCs) to differentiate into various types of cells, including β-cells, has led to a significant boost in development. The efficiency of this differentiation process and the functionality of the cells post-transplantation are crucial factors for the success of stem cell therapy in diabetes. Herein, this article reviews the current advances and challenges faced by stem cell differentiation into functional β-cells for diabetes treatment. In vitro, researchers have sought to enhance the differentiation efficiency of functional β-cells by mimicking the normal pancreatic development process, using gene manipulation, pharmacological and culture conditions stimulation, three-dimensional (3D) and organoid culture, or sorting for functional β-cells based on mature islet cell markers. Furthermore, in vivo studies have also looked at suitable transplantation sites, the enhancement of the transplantation microenvironment, immune modulation, and vascular function reconstruction to improve the survival rate of functional β-cells, thereby enhancing the treatment of diabetes. Despite these advancements, developing stem cells to produce functional β-cells for efficacious diabetes treatment is a continuous research endeavor requiring significant multidisciplinary collaboration, for the stem-cell-derived beta cells to evolve into an effective cellular therapy.

Keywords: Diabetes; Functional β-cells; Stem cell transplantation; Stem cells.

PubMed Disclaimer

References

    1. L. Wang, W. Peng, Z. Zhao, M. Zhang, Z. Shi, Z. Song, X. Zhang, C. Li, Z. Huang, X. Sun, L. Wang, M. Zhou, J. Wu, Y. Wang, Prevalence and treatment of diabetes in China, 2013–2018. JAMA 326, 2498–2506 (2021). https://doi.org/10.1001/jama.2021.22208 - DOI - PubMed - PMC
    1. W. Bielka, A. Przezak, P. Molęda, E. Pius-Sadowska, B. Machaliński, Double diabetes-when type 1 diabetes meets type 2 diabetes: definition, pathogenesis and recognition. Cardiovasc. Diabetol. 23, 62 (2024). https://doi.org/10.1186/s12933-024-02145-x - DOI - PubMed - PMC
    1. M. Lipsett, R. Aikin, M. Castellarin, S. Hanley, A.M. Jamal, S. Laganiere, L. Rosenberg, Islet neogenesis: a potential therapeutic tool in type 1 diabetes. Int. J. Biochem. Cell Biol. 38, 498–503 (2006). https://doi.org/10.1016/j.biocel.2005.08.022 - DOI - PubMed
    1. A. Cañibano-Hernández, L. Sáenz Del Burgo, A. Espona-Noguera, J. Ciriza, J.L. Pedraz, Current advanced therapy cell-based medicinal products for type-1-diabetes treatment. Int. J. Pharm. 543, 107–120 (2018). https://doi.org/10.1016/j.ijpharm.2018.03.041 - DOI - PubMed
    1. J.B. Sneddon, Q. Tang, P. Stock, J.A. Bluestone, S. Roy, T. Desai, M. Hebrok, Stem cell therapies for treating diabetes: progress and remaining challenges. Cell Stem Cell 22, 810–823 (2018). https://doi.org/10.1016/j.stem.2018.05.016 - DOI - PubMed - PMC

MeSH terms

LinkOut - more resources